Ushio Inc. began domestic sales of the “Cerabeam UV308 Pro” ultraviolet therapy equipment for dermatology on 1 October 2026. The Cerabeam UV308 series has been used at approximately 1,500 facilities since its launch in 2008.
Ushio Inc. announced that it would begin domestic sales of the “Cerabeam UV308 Pro” ultraviolet therapy equipment for dermatology on 1 October 2026. The new model expands the available options within the existing UV308 series.
The Cerabeam UV308 Pro has been used in medical settings for many years as an excimer light phototherapy device. The UV308 series lineup includes the new model and the existing “Cerabeam UV308 mini LED,” providing options suited to the operating policies of medical institutions.
The model is covered under health insurance at 340 points for dermatology procedure J054, mid-wave ultraviolet therapy. The date of its inclusion in the health insurance fee schedule is 1 September 2026. Conditions covered include psoriasis and alopecia areata.